Cargando…

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

Detalles Bibliográficos
Autores principales:	Alanio, Alexandre, Dellière, Sarah, Fodil, Sofiane, Bretagne, Stéphane, Mégarbane, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239617/ https://www.ncbi.nlm.nih.gov/pubmed/32445626 http://dx.doi.org/10.1016/S2213-2600(20)30237-X

Ejemplares similares

The presence of Pneumocystis jirovecii in critically ill patients with COVID-19
por: Alanio, Alexandre, et al.
Publicado: (2021)

Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?
por: Dellière, Sarah, et al.
Publicado: (2022)

Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort
por: Dellière, Sarah, et al.
Publicado: (2021)

COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review
por: Benhadid-Brahmi, Yasmine, et al.
Publicado: (2022)

Infections fongiques invasives chez le patient admis en réanimation avec le COVID-19 : une cohorte rétrospective
por: Dellière, S., et al.
Publicado: (2020)

Challenges in microbiological diagnosis of invasive Aspergillus infections
por: Alanio, Alexandre, et al.
Publicado: (2017)

Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
por: Alanio, Alexandre, et al.
Publicado: (2016)

Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study
por: Delsuc, Claire, et al.
Publicado: (2015)

What’s new in invasive pulmonary aspergillosis in the critically ill
por: Koulenti, Despoina, et al.
Publicado: (2014)

Quantification of Pneumocystis jirovecii: Cross-Platform Comparison of One qPCR Assay with Leading Platforms and Six Master Mixes
por: Dellière, Sarah, et al.
Publicado: (2019)

Prevalence and outcome of invasive pulmonary aspergillosis in critically ill patients with liver cirrhosis: an observational study
por: Lahmer, Tobias, et al.
Publicado: (2019)

Severe Thrombotic Thrombocytopenic Purpura (TTP) with Organ Failure in Critically Ill Patients
por: Fodil, Sofiane, et al.
Publicado: (2022)

Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients
por: Lamoth, Frederic, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19
por: Benedetti, María Fernanda, et al.
Publicado: (2022)

Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients
por: Trof, R. J., et al.
Publicado: (2007)

Severe ARDS in a critically ill influenza patient with invasive pulmonary aspergillosis
por: Pietsch, Urs, et al.
Publicado: (2016)

A Comparison of Diagnostic Criteria for Invasive Pulmonary Aspergillosis in Critically Ill Patients
por: Liu, Rui-ting, et al.
Publicado: (2023)

Pneumocystis jirovecii detection in asymptomatic patients: what does its natural history tell us?
por: Alanio, Alexandre, et al.
Publicado: (2017)

Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review
por: Bernardeschi, Céline, et al.
Publicado: (2015)

Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU – A case report
por: Ghelfenstein-Ferreira, Théo, et al.
Publicado: (2020)

Imported leishmaniasis in travelers: a 7-year retrospective from a Parisian hospital in France
por: Aissaoui, Nesrine, et al.
Publicado: (2021)

Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort
por: Versyck, Maaike, et al.
Publicado: (2021)

New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU
por: Hamam, Joffrey, et al.
Publicado: (2021)

Impact of Invasive Pulmonary Aspergillosis in Critically Ill Surgical Patients with or without Solid Organ Transplantation
por: Dubler, Simon, et al.
Publicado: (2023)

Emergence of Difficult-to-Treat Tinea Corporis Caused by Trichophyton mentagrophytes Complex Isolates, Paris, France
por: Dellière, Sarah, et al.
Publicado: (2022)

Invasive Pulmonary Aspergillosis
por: Ledoux, Marie-Pierre, et al.
Publicado: (2023)

Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
por: Egger, Matthias, et al.
Publicado: (2022)

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial
por: Vanderbeke, Lore, et al.
Publicado: (2021)

1175. Pulmonary Aspergillosis in Critically Ill Patients with COVID-19: A Case Series
por: Mitaka, Hayato, et al.
Publicado: (2020)

Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis
por: Maurer, H. Carlo, et al.
Publicado: (2022)

Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance
por: Dellière, Sarah, et al.
Publicado: (2016)

Putative invasive pulmonary aspergillosis in apparently immunocompetent patients within medical wards and intensive care units
por: Edun, Babatunde, et al.
Publicado: (2021)

CD8(+) T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis
por: Cui, Na, et al.
Publicado: (2013)

Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study
por: Lahmer, Tobias, et al.
Publicado: (2021)

COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave
por: Bretagne, Stéphane, et al.
Publicado: (2021)

Invasive aspergillosis in critically ill hematology patients: outcomes and prognostic factors associated with mortality
por: Burghi, G, et al.
Publicado: (2011)

Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes
por: Taccone, Fabio Silvio, et al.
Publicado: (2015)

356. Clinical characteristics of critically ill patients with COVID-19 and invasive pulmonary aspergillosis: a case series from Mexico City
por: VALENTE-ACOSTA, Benjamin, et al.
Publicado: (2020)

279. Clinical Characteristics of Critically Ill Patients with COVID-19 and Invasive Pulmonary Aspergillosis: A Case Series From Mexico City
por: Galindo-Lopez, Patricia, et al.
Publicado: (2021)

Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients
por: Voicu, Sebastian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gdfvja6ov2t9gg2g6hje8cmimf